منابع مشابه
Re: Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities.
OBJECTIVE To study the usage, efficacy, and side effects patterns of atypical neuroleptics (atypicals) in adolescents and young adults with developmental disabilities (DDs) (mental retardation). METHOD We undertook a chart review of adolescents and young adults (under age 25 years) seen by our specialized mental health team. RESULTS Risperidone and olanzapine were by far the most frequently...
متن کاملWeight gain with clozapine compared to first generation antipsychotic medications.
Few studies have examined gender differences in the propensity to gain weight on clozapine. Weight gain increases risk for many medical illnesses and is of particular concern for people with schizophrenia who are more overweight than the general population. Long-stay patients in Connecticut state hospitals were randomly assigned to switch to open-label treatment with clozapine (n = 138) or to c...
متن کاملBehavioral weight loss treatment for youth treated with antipsychotic medications
Background: Youth who are being treated with antipsychotic medications are at increased risk for the development of obesity and type 2 diabetes. Behavioral weight loss treatments show promise for reducing obesity and diabetes risk among adults treated with these drugs, but such treatments have not previously been studied in youth. Objective: We describe a rationale for behavioral weight loss in...
متن کاملWeight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs.
Atypical antipsychotics (AA) are generally associated with weight gain. We determined body mass index (BMI) change in Parkinson's disease (PD) before and after taking AA and compared against PD controls and Alzheimer's disease (AD) patients on AA. In 66 consecutive PD subjects started on AA who had accurate weights for more than 6 months before and after initiation of AA, we compared weight cha...
متن کاملArtificial sweetener use and one-year weight change among women.
Weight change over a 1-year period was examined in a highly homogeneous group of 78,694 women ages 50-69 enrolled in a prospective mortality study. Artificial sweetener usage increased with relative weight and decreased with age. Users were significantly more likely than nonusers to gain weight, regardless of initial weight. Average weight gains or losses by artificial sweetener users differed ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Canadian Journal of Psychiatry
سال: 2001
ISSN: 0706-7437,1497-0015
DOI: 10.1177/070674370104600721